Related Experiment Video
Updated: Aug 13, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural
Harry Bulstrode1, Gemma C Girdler1, Tannia Gracia2
1Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK; Division of Academic Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
Abstract:
Zika virus (ZIKV) can infect human developing brain (HDB) progenitors resulting in epidemic microcephaly, whereas analogous cellular tropism offers treatment potential for the adult brain cancer, glioblastoma (GBM). We compared productive ZIKV infection in HDB and GBM primary tissue explants that both contain SOX2+ neural progenitors. Strikingly, although the HDB proved uniformly vulnerable to ZIKV infection, GBM was more refractory, and this correlated with an innate immune expression signature. Indeed, GBM-derived CD11b+ microglia/macrophages were necessary and sufficient to protect progenitors against ZIKV infection in a non-cell autonomous manner. Using SOX2+ GBM cell lines, we found that CD11b+-conditioned medium containing type 1 interferon beta (IFNβ) promoted progenitor resistance to ZIKV, whereas inhibition of JAK1/2 signaling restored productive infection. Additionally, CD11b+ conditioned medium, and IFNβ treatment rendered HDB progenitor lines and explants refractory to ZIKV. These findings provide insight into neuroprotection for HDB progenitors as well as enhanced GBM oncolytic therapies.
Insights
Zika virus infects developing brain cells, causing microcephaly. Glioblastoma cells, however, resist infection due to microglia-mediated innate immunity, offering potential for brain cancer therapies.
Area of Science:
- Neuroscience
- Virology
- Immunology
Background:
- Zika virus (ZIKV) causes microcephaly by infecting human developing brain (HDB) progenitors.
- Glioblastoma (GBM), an adult brain cancer, shares cellular tropism with HDB, suggesting therapeutic potential.
- SOX2+ neural progenitors are present in both HDB and GBM tissues.
Purpose of the Study:
- To compare ZIKV infection susceptibility in HDB and GBM primary tissue explants.
- To investigate the role of innate immunity in ZIKV resistance in GBM.
- To explore therapeutic strategies for ZIKV-induced microcephaly and GBM oncolysis.
Main Methods:
- Primary tissue explants from HDB and GBM were infected with ZIKV.
- SOX2+ GBM cell lines and HDB progenitor lines were utilized.
- Conditioned medium from CD11b+ microglia/macrophages and type 1 interferon beta (IFNβ) were applied.
- JAK1/2 signaling inhibition was employed to assess its effect on ZIKV infection.
Main Results:
- HDB progenitors were uniformly vulnerable to ZIKV infection.
- GBM tissues exhibited resistance to ZIKV, correlated with an innate immune signature.
- GBM-derived CD11b+ microglia/macrophages conferred non-cell autonomous protection against ZIKV.
- IFNβ, present in CD11b+-conditioned medium, induced resistance in both GBM and HDB progenitors.
- JAK1/2 inhibition restored productive ZIKV infection in GBM progenitors.
Conclusions:
- GBM-associated innate immunity, particularly from microglia/macrophages, protects neural progenitors from ZIKV.
- IFNβ signaling is a key mechanism for ZIKV resistance in both developing and adult brain contexts.
- These findings offer insights for neuroprotection strategies and enhancing oncolytic virotherapy for glioblastoma.
More Related Videos
Related Concept Videos
Arboviral Encephalitis
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release

